Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Destination: This competitive grant program seeks to support research conducted by Junior Investigators that advances medical knowledge in the understanding, diagnosis and treatment of ATTR Amyloidosis. Pfizer is interested in supporting research proposals that advance our understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR amyloidosis.
Fill out the form below to receive more information:
Collaborate with the IISPV and help us improve people's health through research!